Literature DB >> 9753199

Traumatic brain injury causes delayed motor and cognitive impairment in a mutant mouse strain known to exhibit delayed Wallerian degeneration.

G B Fox1, A I Faden.   

Abstract

Delayed Wallerian degeneration after neuronal injury is a feature of the C57BL/Wld(s) mouse mutant. In the present study, we examined the effect of unilateral controlled cortical impact (CCI) on motor and cognitive performance in C57BL/6 and C57BL/Wld(s) mice. Performance on a beam-walking task was impaired in both injured groups over the first 3 weeks; however, between 28 and 35 days post injury, C57BL/6 mice continued to improve whereas C57BL/Wld(s) mice showed increased footfaults. In a spatial learning task, C57BL/Wld(s) animals performed consistently better than C57BL/6 mice when tested 7-10 days and 14-17 days following CCI. C57BL/Wld(s) mice also demonstrated improved working memory performance as compared with C57BL/6 mice when trained on days 21-22 after injury; this effect was lost on days 23 and 24, and was not evident in other animals tested in the same task at 28-31 days following injury. These results indicate a marked delay in motor and cognitive impairment following CCI in C57BL/Wld(s) mice compared with injured C57BL/6 controls. This is consistent with previous work showing delayed temporal evolution of neuronal degeneration in C57BL/Wld(s) mice and suggests CCI may be a suitable model for examining the functional consequences of traumatic brain injury (TBI) in genetically altered mice.

Entities:  

Mesh:

Year:  1998        PMID: 9753199     DOI: 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.0.CO;2-8

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  24 in total

1.  Delayed axonal degeneration in slow Wallerian degeneration mutant mice detected using diffusion tensor imaging.

Authors:  M Xie; Q Wang; T-H Wu; S-K Song; S-W Sun
Journal:  Neuroscience       Date:  2011-09-25       Impact factor: 3.590

Review 2.  Emergence of SARM1 as a Potential Therapeutic Target for Wallerian-type Diseases.

Authors:  Heather S Loring; Paul R Thompson
Journal:  Cell Chem Biol       Date:  2019-11-21       Impact factor: 8.116

3.  Identification of the first noncompetitive SARM1 inhibitors.

Authors:  Heather S Loring; Sangram S Parelkar; Santanu Mondal; Paul R Thompson
Journal:  Bioorg Med Chem       Date:  2020-07-17       Impact factor: 3.641

Review 4.  Animal models of traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Nat Rev Neurosci       Date:  2013-02       Impact factor: 34.870

Review 5.  Chronic Histopathological and Behavioral Outcomes of Experimental Traumatic Brain Injury in Adult Male Animals.

Authors:  Nicole D Osier; Shaun W Carlson; Anthony DeSana; C Edward Dixon
Journal:  J Neurotrauma       Date:  2015-04-15       Impact factor: 5.269

6.  Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views.

Authors:  Deng-Shun Wang; Dennis W Dickson; James S Malter
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

7.  Longitudinal volumetric changes following traumatic brain injury: a tensor-based morphometry study.

Authors:  Kimberly D M Farbota; Aparna Sodhi; Barbara B Bendlin; Donald G McLaren; Guofan Xu; Howard A Rowley; Sterling C Johnson
Journal:  J Int Neuropsychol Soc       Date:  2012-08-13       Impact factor: 2.892

8.  Inhibition of Nogo-66 receptor 1 enhances recovery of cognitive function after traumatic brain injury in mice.

Authors:  Jing Tong; Weimin Liu; Xiaowei Wang; Xiaodi Han; Ollivier Hyrien; Uzma Samadani; Douglas H Smith; Jason H Huang
Journal:  J Neurotrauma       Date:  2013-02-04       Impact factor: 5.269

Review 9.  The Controlled Cortical Impact Model of Experimental Brain Trauma: Overview, Research Applications, and Protocol.

Authors:  Nicole Osier; C Edward Dixon
Journal:  Methods Mol Biol       Date:  2016

10.  Central Infusion of Insulin-Like Growth Factor-1 Increases Hippocampal Neurogenesis and Improves Neurobehavioral Function after Traumatic Brain Injury.

Authors:  Shaun W Carlson; Kathryn E Saatman
Journal:  J Neurotrauma       Date:  2018-04-17       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.